Quotient Sciences Quotient Sciences

X
menu

    Market Place

    Market Place

    Post Enquiry

    Post Enquiry
    menu

    Digital content for Regeneron Pharmaceuticals

    Client Virtual Booth

    REGENERON PHARMACEUTICALS

    EVENTS

    • Webinars & Exhibitions

    PRESENTATION(s)

    VIDEO(s)

    DIGITAL CONTENT

    APIs // Active Pharmaceutical Ingredients

    DEVELOPMENTS

    DOSSIERs // Finished Dosage Formulations

    INSPECTIONS & REGISTRATIONS

    PharmaCompass
    Contact SupplierContact Supplier
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Send me more info on How To Grow My Bussiness Digitally?
    Regeneron Pharmaceuticals
    United_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    777 Old Saw Mill River Road Tarrytown, NY 10591
    Telephone
    Telephone
    +1 914-847-7000
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.regeneron.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company-beta/13476?pathWildcard=13476
    Twitter
    Twitter
    https://twitter.com/regeneron

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    left grey arrow
    right gray arrow
    Full View ScreenFull Screen View
    US FDA warns of harmful reactions to fake Botox injections
    US FDA warns of harmful reactions to fake Botox injections

    https://www.reuters.com/business/healthcare-pharmaceuticals/us-fda-warns-harmful-reactions-fake-botox-injections-2024-04-16/

    REUTERS
    17 Apr 2024
    Share Share
    Regeneron Launches $500M Venture Capital Fund Skewed Toward Biotech
    Regeneron Launches $500M Venture Capital Fund Skewed Toward Biotech

    https://www.biospace.com/article/regeneron-launches-500m-venture-capital-fund-skewed-toward-biotech/

    Tyler Patchen BIOSPACE
    15 Apr 2024
    Share Share
    US accuses Regeneron of fraudulent price reporting for eye drug
    US accuses Regeneron of fraudulent price reporting for eye drug

    https://www.reuters.com/legal/us-justice-department-files-complaint-against-regeneron-alleges-fraudulent-drug-2024-04-10/

    Nate Raymond REUTERS
    12 Apr 2024
    Share Share
    Regeneron Present Pivotal Data of Linvoseltamab at AACR
    Regeneron Present Pivotal Data of Linvoseltamab at AACR

    https://www.globenewswire.com/news-release/2024/04/07/2858843/0/en/Linvoseltamab-Pivotal-Data-Presented-at-AACR-Reinforce-High-Response-Rate-that-Deepens-Over-Time-in-Patients-with-Heavily-Pre-Treated-Multiple-Myeloma.html

    GLOBENEWSWIRE
    07 Apr 2024
    Share Share
    2seventy bio Announces Completion of Pipeline Divestiture to Regeneron
    2seventy bio Announces Completion of Pipeline Divestiture to Regeneron

    https://www.businesswire.com/news/home/20240401936098/en

    BUSINESSWIRE
    01 Apr 2024
    Share Share
    Regeneron to Report First Quarter 2024 Financial and Operating Results
    Regeneron to Report First Quarter 2024 Financial and Operating Results

    https://www.globenewswire.com/news-release/2024/04/01/2855420/0/en/Regeneron-to-Report-First-Quarter-2024-Financial-and-Operating-Results-and-Host-Conference-Call-and-Webcast-on-May-2-2024.html

    GLOBENEWSWIRE
    01 Apr 2024
    Share Share
    FDA Rejects Regeneron’s Blood Cancer Therapy for Two Forms of Lymphoma
    FDA Rejects Regeneron’s Blood Cancer Therapy for Two Forms of Lymphoma

    https://www.biospace.com/article/fda-rejects-regeneron-s-bood-cancer-therapy-for-two-forms-of-lymphoma/

    Tyler Patchen BIOSPACE
    26 Mar 2024
    Share Share
    Regeneron Provides Update on Biologics License Application for Odronextamab
    Regeneron Provides Update on Biologics License Application for Odronextamab

    https://www.globenewswire.com/news-release/2024/03/25/2851488/0/en/Regeneron-Provides-Update-on-Biologics-License-Application-for-Odronextamab.html

    GLOBENEWSWIRE
    25 Mar 2024
    Share Share
    Appeals court reverses Novartis win over Regeneron in Eylea-Lucentis battle
    Appeals court reverses Novartis win over Regeneron in Eylea-Lucentis battle

    https://endpts.com/appeals-court-reverses-novartis-win-over-regeneron-in-eylea-lucentis-battle/

    ENDPTS
    18 Mar 2024
    Share Share
    High School Seniors Win $1.8 Million at Regeneron Science Talent Search 2024
    High School Seniors Win $1.8 Million at Regeneron Science Talent Search 2024

    https://www.globenewswire.com//news-release/2024/03/13/2845129/0/en/High-School-Seniors-Win-1-8-Million-at-Regeneron-Science-Talent-Search-2024-for-Innovative-Scientific-Research-on-Artificial-Intelligence-Cancer-Metabolism-and-Mathematical-Optimiz.html

    GLOBENEWSWIRE
    12 Mar 2024
    Share Share
    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    polpharma-m-2024-04-15

    Access Virtual Booth

    Contact Supplier

    Send me more info on How To Grow My Business Digitally?
    Post Enquiry
    POST ENQUIRY

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search